Kidney transplant and Optic atrophy

Summary:

Optic atrophy is found among people with Kidney transplant, especially for people who are male, 60+ old.

The study analyzes which people have Optic atrophy with Kidney transplant. It is created by eHealthMe based on reports of 28 people who have Kidney transplant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Kidney transplant?

Kidney transplant is found to be associated with 299 drugs and 547 conditions by eHealthMe. Check the latest studies of Kidney transplant.

What is Optic atrophy?

Optic atrophy (the loss of a proportion of optic disc nerve fibres) is found to be associated with 249 drugs and 453 conditions by eHealthMe. Check the latest studies of Optic atrophy.

On Jul, 26, 2026

28 people who have Kidney Transplant and Optic Atrophy are studied.

Would you have Optic atrophy when you have Kidney transplant?

Gender of people who have Kidney Transplant and experienced Optic Atrophy *:

female: 18.52 %
male: 81.48 %

Age of people who have Kidney Transplant and experienced Optic Atrophy *:

Common co-existing conditions for these people *:

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 21.43%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 21.43%
High Blood Pressure: 6 people, 21.43%
Hepatitis B: 6 people, 21.43%
Immunodeficiency Disorders: 5 people, 17.86%
Focal Segmental Glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli): 1 person, 3.57%

Common drugs taken by these people *:

Common symptoms for these people *:

Papilloedema (optic disc swelling): 8 people, 28.57%
Visual Field Defect: 7 people, 25.00%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 6 people, 21.43%
Constipation: 6 people, 21.43%
High Blood Cholesterol: 6 people, 21.43%
Hyperthyroidism (over activity of the thyroid gland): 6 people, 21.43%
Hypertriglyceridaemia (excess of triglycerides in the blood): 6 people, 21.43%
Optic Nerve Disorder (disease of optic nerve): 6 people, 21.43%
Anaemia (lack of blood): 6 people, 21.43%
Toxic Optic Neuropathy (optic nerve damage caused by toxic (harmful) substances): 6 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Optic atrophy?

- Check whether Optic atrophy is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Kidney transplant (48,961 reports)
Optic atrophy (2,242 reports)

All the drugs that are associated with Optic atrophy:

Optic atrophy (249 drugs)

All the conditions that are associated with Optic atrophy:

Optic atrophy (453 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Optic atrophy and Kidney transplant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.